IP Library Granted Patent US 11,297,445
Granted Patent B2
US 11,297,445 · App. 16/540,435 · Granted Apr 5, 2022

Methods and devices for treating primary headache

Inventors: Bruce J. Simon (Mountain Lakes, NJ); Joseph P. Errico (Warren, NJ); John T. Raffle (Austin, TX)
Assignee: ELECTROCORE, INC.
H04R25/505A61N1/0456A61N1/36021A61N1/36034A61N1/40A61N2/008A61N2/02H04R25/305H04R25/70A61N1/36075A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,297,445
App. No.
16/540,435
Granted
Apr 5, 2022
Kind
B2
Abstract

Non-invasive electrical nerve stimulation devices and magnetic stimulation devices are disclosed, along with methods of treating medical disorders using energy that is delivered noninvasively by such devices. The disorders comprise migraine and other primary headaches such as cluster headaches, including sinus symptoms that resemble an immune-mediated response (“sinus” headaches), irrespective of whether those symptoms arise from an allergy that is co-morbid with the headache. The disclosed methods may also be used to treat other disorders that may be co-morbid with migraine headaches, such as anxiety disorders. In preferred embodiments of the disclosed methods, one or both of the patient's vagus nerves are stimulated non-invasively. In other embodiments, parts of the sympathetic nervous system and/or the adrenal glands are stimulated.

Claims (28)

1. A method for treating a medical disorder in a patient, the method comprising:

positioning a device comprising a housing and a source of energy, wherein the housing comprises a contact surface;

generating one or more electrical impulses within the device;

contacting an outer skin surface of the patient with the contact surface; and

transmitting, via the device, the one or more electrical impulses through the outer skin surface of the patient to a vague nerve of the patient, wherein the one or more electrical impulses is above a threshold for generating an action potential within a fiber of the vagus nerve responsible for activating neural pathways to cause a release of a sufficient level of GABA within a brain of the patient to at least partially relieve a symptom associated with the medical disorder.

2. The method of claim 1 wherein the one or more electrical impulses is sufficient to cause a release of serotonin within the brain of the patient.

3. The method of claim 1 wherein the one or more electrical impulses is sufficient to cause a release of norepinephrine within the brain of the patient.

4. The method of claim 1 wherein the one or more electrical impulses is sufficient to reduce a level of glutamate in a brain of the patient.

5. The method of claim 1 wherein the one or more electrical impulses comprises bursts of pulses.

6. The method of claim 5 wherein the bursts of pulses are generated from a signal that is not modulated by another signal.

7. The method of claim 5 wherein each burst comprises a frequency from about 1 Hz to about 100 Hz.

8. The method of claim 5 wherein each pulse comprises a duration from about 50 microseconds to about 1000 microseconds.

9. The method of claim 5 wherein each pulse comprises a duration from about 200 microseconds to about 400 microseconds.

10. The method of claim 1 further comprising transmitting the one or more electrical impulses from one or more electrodes coupled to the device.

11. A device for treating a medical disorder in a patient, the device comprising:

a housing comprising:

an electrode;

a source of energy (1) configured to generate an electric field sufficient to at least partially relieve a symptom of the medical disorder, (b) coupled to the electrode, and (c) positioned within the housing; and

wherein the electrical field is sufficient to transmit one or more electrical impulses non-invasively through the electrode and the outer skin surface of the patient to a vague nerve of the patient, wherein the one or more electrical impulses is above a threshold for generating an action potential within a fiber of the vagus nerve responsible for activating a neural pathway causing a release of GABA within a brain of the patient.

12. The device of claim 11 wherein the one or more electrical impulses is sufficient to cause a release of serotonin within the brain of the patient.

13. The device of claim 11 wherein the one or more electrical impulses is sufficient to cause a release of norepinephrine within the brain of the patient.

14. The device of claim 11 wherein the one or more electrical impulses is sufficient to reduce a level of glutamate in a brain of the patient.

15. The device of claim 11 wherein the one or more electrical impulses comprises bursts of pulses.

16. The device of claim 15 wherein the bursts of pulses are generated from a signal that is not modulated by another signal.

17. The device of claim 15 wherein each burst comprises a frequency from about 1 Hz to about 100 Hz.

18. The device of claim 15 wherein each pulse comprises a duration from about 50 microseconds to about 1000 microseconds.

19. The device of claim 15 wherein each pulse comprises a duration from about 200 microseconds to about 400 microseconds.

20. The device of claim 11 wherein the source of energy comprises a signal generator.

Assignments (2)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: SIMON, BRUCE J.; ERRICO, JOSEPH P.; RAFFLE, JOHN T.
To: ELECTROCORE, INC.
Reel/Frame 050050/0617 →
Continuity (22)
Division 14992921 · Jan 11, 2016
Continuation 14229894 · Mar 29, 2014
Division 13109250 · May 17, 2011
Continuation In Part 13075746 · Mar 30, 2011
Continuation In Part 13024727 · Feb 10, 2011
Continuation In Part 13005005 · Jan 12, 2011
Continuation In Part 12964050 · Dec 9, 2010
Continuation In Part 12859568 · Aug 19, 2010
Continuation In Part 12612177 · Nov 4, 2009
Continuation In Part 12408131 · Mar 20, 2009
Continuation In Part 11592095 · Nov 2, 2006
Continuation In Part 11591340 · Nov 1, 2006
Provisional Application 61471405 · Apr 4, 2011
Provisional Application 61451259 · Mar 10, 2011
Provisional Application 61415469 · Nov 19, 2010
Provisional Application 60814312 · Jun 16, 2006
Provisional Application 60814313 · Jun 16, 2006
Provisional Application 60786564 · Mar 28, 2006
Provisional Application 60772361 · Feb 10, 2006
Provisional Application 60736002 · Nov 10, 2005
Provisional Application 60736001 · Nov 10, 2005
Related Publication 20190374773A1 · Dec 12, 2019